News Search Results
Sep 09, 2025, 22:49 ET ImmVira Announces First-in-Human Data of Engineered Exosome MVR-EX105 for Fat Reduction and Muscle Preservation by Topical Application at 2025 Annual Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders
professional-grade at-home solutions for localized fat reduction. About ImmVira ImmVira is a global leading clinical-stage biotechnology company that is powered by proprietary biological engineering technology, and is dedicated to the discovery, development, manufacture and commercialization
More news about: ImmVira
![Partner Therapeutics Receives EMA Approval of IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive Doses of Radiation (Hematopoietic Sub-syndrome of Acute Radiation Syndrome [H-ARS])](https://mma.prnewswire.com/media/633165/PTx_updated_logo.jpg?w=300){kind=logo}
Sep 09, 2025, 13:42 ET Partner Therapeutics Receives EMA Approval of IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive Doses of Radiation (Hematopoietic Sub-syndrome of Acute Radiation Syndrome [H-ARS])
https://ec.europa.eu/health/documents/community-register/2025/20250821166908/anx_166908_en.pdf. ABOUT PARTNER THERAPEUTICSPartner Therapeutics, Inc. (PTx), an integrated biotechnology company, focuses on development and commercialization of late-stage therapeutics to improve health outcomes in treatment serious diseases and to
More news about: Partner Therapeutics, Inc.
Sep 09, 2025, 11:22 ET Marshmallow Market Is Expected To Reach US$3.46 Billion By 2031 At CAGR Of 7.4% During The Forecast Period |The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 09, 2025, 11:00 ET TCI Biotech Strengthens Global Leadership Team with Appointment of Sales VP Tony Hatori and Strategic Consultant Alan Roberts
SALT LAKE CITY, Utah, Sept. 9, 2025 /PRNewswire/ -- TCI, a global biotechnology leader in health and wellness innovation, today announced key leadership appointments to accelerate its international growth. Tony
More news about: TCI; TCI Bio
Sep 09, 2025, 10:43 ET GBI Biomanufacturing Partners with NanoRetinal to Advance Vision-Restoring Therapy for Inherited Retinal Diseases
analytical characterization, and GMP manufacturing of complex biologics. NanoRetinal NanoRetinal is a biotechnology company dedicated to developing life-changing treatments for patients with IRD through applications of their proprietary nanoparticulate technology.
More news about: GBI Biomanufacturing
Sep 09, 2025, 10:05 ET 3D Printing Market to Reach USD 210.5 Billion by 2035 | Growing at a CAGR of 24.25% - Vantage Market Research
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 09, 2025, 10:01 ET Whey Powder Market Size is Expected to Reach US$5.80 Billion By 2031 at CAGR Of 5.5% During The Forecast Period | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 09, 2025, 09:14 ET NeuroKaire launches first-of-its-kind clinical test in the US, expected to dramatically reduce the 'trial and error' approach to finding the right antidepressant
fewer side effects, lower dosing, and the elimination of arduous trial-and-error treatment protocols. NeuroKaire also enables pharmaceutical and biotechnology companies to bring precision medicine into drug development throughout the developmental pipeline across psychiatry and neurology. For more information
More news about: NeuroKaire
Sep 09, 2025, 09:00 ET Hydrosome Labs Reveals Promising Fermentation Breakthrough Using Ultrafine Bubbles
Hydrosome Labs, a Chicago-based biotechnology company pioneering ultrafine bubble (UFB) technology, today announced new findings from a study with Biocell Energetics, a venture from the
More news about: Hydrosome Labs
Sep 09, 2025, 09:00 ET Neuvian Skincare Granted Breakthrough U.S. Patent for Dual Peptide Skin Technology
Skincare:Founded in 2024 and based in Miami, FL, Neuvian Skincare is a beauty-tech brand applying organic chemistry, biotechnology, and
More news about: Neuvian Skincare
Sep 09, 2025, 09:00 ET iRegene Therapeutics Secures Series B+ Financing Following FDA Fast Track Designation for its Flagship Product NouvNeu001
9, 2025 /PRNewswire/ -- iRegene Therapeutics (Chengdu) Co., Ltd. ("iRegene" or the "Company"), a biotechnology company pioneering chemically induced allogeneic cell therapy, announced on September 4th the successful completion
More news about: iRegene therapeutics
Sep 09, 2025, 09:00 ET MATTER OF FACT AWARDED U.S. PATENT FOR VITAMIN C STABILIZATION TECHNOLOGY
entrepreneurs are known for their work on Olaplex and K18 Hair, and as brand architects behind Goddess Maintenance Co.'s Biotech Blowout. Focusing on biotechnology, they foster advancements in skin and hair care. Next8 Investments supports emerging beauty and biotech founders while pioneering technologies in
More news about: MATTER OF FACT
Sep 09, 2025, 09:00 ET Kytopen Announces Collaboration with BlueWhale Bio to Revolutionize Cell Therapy Manufacturing
across a range of cell types, payloads, and therapeutic applications. Kytopen has recently disclosed strategic partnerships with industry-leading biotechnology companies, contract development and manufacturing organizations (CDMOs), and cell therapy-focused medical centers. Kytopen continues to engage strategic
More news about: Kytopen
Sep 09, 2025, 08:51 ET TheWell Bioscience Launches VitroGel® NEURON, a First-Of-Its-Kind Synthetic Hydrogel for Superior 3D, 2D Neuronal Cell Culture and Beyond
[email protected]. About TheWell Bioscience Inc. TheWell Bioscience Inc. is a pioneering biotechnology company dedicated to advancing 3D cell culture and tissue engineering through the innovative xeno-free VitroGel® hydrogel platforms. The VitroGel®
More news about: TheWell Bioscience Inc.
Sep 09, 2025, 08:33 ET Gallant Debuts GallantU: A Comprehensive CE Platform Preparing Veterinary Professionals for the Regenerative Medicine Era
Gallant, an animal health biotechnology company pioneering ready-to-use stem cell therapies for pets, announced the launch of its proprietary online continuing education (CE) platform,
More news about: Gallant
Sep 09, 2025, 08:30 ET Advancing Cell Therapies: From IND to BLA with Scalable CMC Strategies, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 09, 2025, 08:30 ET Improving Clinical Response Signaling in Rare Disease Studies with Targeted Endpoint Data Quality Programs, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 09, 2025, 08:30 ET Patient Identification for Clinical Trials Through AI and Real-World Data, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 09, 2025, 08:00 ET Lilly launches new "Brain Health Matters" campaign in partnership with Julianne Moore, empowering the public to prioritize brain health
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Sep 09, 2025, 07:00 ET Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment
datasets used to train an AI system available to biotechnology companies. "Lilly has spent decades building comprehensive datasets for drug discovery. Today, we're sharing the intelligence gained from that investment to help lift the tide of biotechnology research," said Daniel
More news about: Eli Lilly and Company
Sep 09, 2025, 07:00 ET Deerfield Group Evolves Agency Brand Identity to Reflect Unique Approach to Scalable, Flexible Solutions for Healthcare Clients
GroupDeerfield Group is a full-service integrated marketing, advertising, and communications agency providing innovative solutions for pharmaceutical, biotechnology, health tech, and consumer health companies. Deerfield's solutions are designed to meet the unique needs of healthcare
More news about: Deerfield Group
Sep 09, 2025, 07:00 ET Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025
the skin, leading to an immune reaction and inflammation. About Nektar Therapeutics Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases.
More news about: Nektar Therapeutics
Sep 09, 2025, 06:32 ET Insect Pest Control Market Size Is Expected to Reach US$ 21.33 Billion By 2031 at A CAGR Of 5.4% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 09, 2025, 06:30 ET Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today
More news about: Immunic, Inc.
Sep 09, 2025, 06:30 ET Ascletis Announces Ultra-Long-Acting Subcutaneous Depot Maintenance Formulation of Small Molecule GLP-1R Agonist ASC30 Demonstrated an Observed Half-Life of 75 Days in Participants with Obesity
patent protection until 2044 without patent extensions. About Ascletis Pharma Inc. Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.